Symposium - European Medical Journal

Continue

Symposiums

Hepatology
27 Jan 2015

The Liver Meeting 2014: Summary of Presentations on Genotype 3 HCV Infection from the 65th Annual Liver Meeting of the American Association for the Study of Liver Diseases (AASLD), Held in Boston, MA, USA, on 7th-11th November, 2014

After genotype 1 (GT1), genotype 3 (GT3) is the second most common hepatitis C virus (HCV) genotype worldwide, with an estimated worldwide prevalence of…
Neurology
9 Dec 2014

New Approaches to Meet Patients’ Needs in Clinical Practice

Migraine is a primary headache disorder affecting up to four in ten women and up to two in ten men, mostly before the age of 35 years.1 By the age of 30…
Dermatology
24 Nov 2014

Optimising the Patient Journey in Chronic Spontaneous Urticaria

Summary of Presentations from the Novartis-Supported Satellite Symposium, held at the 23rd EADV Congress, Amsterdam, on 9th October 2014
Dermatology
24 Nov 2014

Revealing a Clear Path Towards a New Era in the Management of Psoriasis

The meeting provided a bench-to-bedside overview of the targeting of interleukin-17 (IL-17) for the treatment of psoriasis.
Diabetes
31 Oct 2014

Investigating the Different Dimensions of DPP-4 Inhibitors

This Takeda-sponsored European Association for the Study of Diabetes (EASD) symposium addressed the pharmacology, clinical use, and future therapeutic…
Respiratory
24 Oct 2014

There’s more to IgE – Let’s Talk Severe Asthma

The meeting discussed the current understanding of the role of immunoglobulin E (IgE) in asthma, and anti-IgE strategies in the treatment of severe asthma.
Respiratory
24 Oct 2014

COPD Patients’ Needs and Current Treatment Options

The objective of this meeting was to review the complexities surrounding the management and treatment options for different populations of chronic…
Respiratory
24 Oct 2014

Nocturnal Non-Invasive Ventilation for Chronic Obstructive Pulmonary Disease: A Final Breakthrough?

Prof Windisch opened the symposium on the efficacy of non-invasive ventilation (NIV) in the treatment of chronic obstructive pulmonary disease (COPD).
We’ve noticed you’re accessing
from North/South America.